Matches in SemOpenAlex for { <https://semopenalex.org/work/W2013507617> ?p ?o ?g. }
- W2013507617 endingPage "45" @default.
- W2013507617 startingPage "33" @default.
- W2013507617 abstract "Surgical resection remains the only potentially curative option for patients with pancreatic adenocarcinoma (PAC). Advances in surgical technique and perioperative care have reduced perioperative mortality; however, temporal trends in perioperative morbidity and the use of adjuvant therapy on a population basis remain ill-defined.Using Surveillance, Epidemiology, and End Results-Medicare data, 2,461 patients with resected PAC were identified from 1991 to 2005. We examined trends in preoperative comorbidity indices, adjuvant treatment, type of pancreatic resection, and changes in morbidity and mortality during 4 time intervals (ie, 1991-1996, 1997-2000, 2001-2003, and 2003-2005).The majority of patients underwent pancreaticoduodenectomy (n = 1,945; 79%). There was a temporal increase in mean patient age (p < 0.05) and the number of patients with multiple preoperative comorbidities (Elixhauser comorbidities ≥3: 1991-1996, 10% vs 2003-2005, 26%; p < 0.001). Perioperative morbidity (53%) did not, however, change over time (p = 0.97) and 30-day mortality decreased by half (1991-1996: 6% vs 2003-2005: 3%; p = 0.04). Overall, 51% (n = 1,243) of patients received adjuvant therapy, with the majority receiving chemoradiation (n = 817; 33%). Among patients who received adjuvant therapy, factors associated with receipt of adjuvant chemotherapy alone relative to chemoradiation included older patient age (odds ratio = 1.75; p < 0.001) and ≥3 medical comorbidities (odds ratio = 1.57; p = 0.007). Receipt of adjuvant chemotherapy alone also increased over time (2003-2005 vs 1991-1996, odds ratio = 2.21; p < 0.001).Perioperative 30-day mortality associated with resection for PAC decreased by one-half from 1991 to 2005. Although patients undergoing resection for PAC were older and had more preoperative comorbidities, the incidence of perioperative complications remained stable. The relative use of adjuvant chemotherapy alone vs chemoradiation therapy for PAC has increased in the United States during the 15 years examined." @default.
- W2013507617 created "2016-06-24" @default.
- W2013507617 creator A5011285023 @default.
- W2013507617 creator A5016519845 @default.
- W2013507617 creator A5026919131 @default.
- W2013507617 creator A5051619233 @default.
- W2013507617 creator A5053975374 @default.
- W2013507617 creator A5059338254 @default.
- W2013507617 creator A5062862642 @default.
- W2013507617 creator A5075915892 @default.
- W2013507617 creator A5083184392 @default.
- W2013507617 creator A5089299130 @default.
- W2013507617 date "2012-01-01" @default.
- W2013507617 modified "2023-09-30" @default.
- W2013507617 title "Management of Patients with Pancreatic Adenocarcinoma: National Trends in Patient Selection, Operative Management, and Use of Adjuvant Therapy" @default.
- W2013507617 cites W1493790738 @default.
- W2013507617 cites W1930757563 @default.
- W2013507617 cites W1969367131 @default.
- W2013507617 cites W1974173658 @default.
- W2013507617 cites W1974219858 @default.
- W2013507617 cites W1979300931 @default.
- W2013507617 cites W1996267265 @default.
- W2013507617 cites W2014516834 @default.
- W2013507617 cites W2018983979 @default.
- W2013507617 cites W2024996568 @default.
- W2013507617 cites W2027259455 @default.
- W2013507617 cites W2039052985 @default.
- W2013507617 cites W2047318784 @default.
- W2013507617 cites W2050034771 @default.
- W2013507617 cites W2057780602 @default.
- W2013507617 cites W2059768212 @default.
- W2013507617 cites W2071500602 @default.
- W2013507617 cites W2073768319 @default.
- W2013507617 cites W2075284324 @default.
- W2013507617 cites W2081796754 @default.
- W2013507617 cites W2085509059 @default.
- W2013507617 cites W2092138149 @default.
- W2013507617 cites W2108089177 @default.
- W2013507617 cites W2129197203 @default.
- W2013507617 cites W2142809913 @default.
- W2013507617 cites W2158734599 @default.
- W2013507617 cites W2158922990 @default.
- W2013507617 cites W2615088276 @default.
- W2013507617 cites W2029703153 @default.
- W2013507617 doi "https://doi.org/10.1016/j.jamcollsurg.2011.09.022" @default.
- W2013507617 hasPubMedCentralId "https://www.ncbi.nlm.nih.gov/pmc/articles/3578342" @default.
- W2013507617 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/22055585" @default.
- W2013507617 hasPublicationYear "2012" @default.
- W2013507617 type Work @default.
- W2013507617 sameAs 2013507617 @default.
- W2013507617 citedByCount "144" @default.
- W2013507617 countsByYear W20135076172012 @default.
- W2013507617 countsByYear W20135076172013 @default.
- W2013507617 countsByYear W20135076172014 @default.
- W2013507617 countsByYear W20135076172015 @default.
- W2013507617 countsByYear W20135076172016 @default.
- W2013507617 countsByYear W20135076172017 @default.
- W2013507617 countsByYear W20135076172018 @default.
- W2013507617 countsByYear W20135076172019 @default.
- W2013507617 countsByYear W20135076172020 @default.
- W2013507617 countsByYear W20135076172021 @default.
- W2013507617 countsByYear W20135076172022 @default.
- W2013507617 countsByYear W20135076172023 @default.
- W2013507617 crossrefType "journal-article" @default.
- W2013507617 hasAuthorship W2013507617A5011285023 @default.
- W2013507617 hasAuthorship W2013507617A5016519845 @default.
- W2013507617 hasAuthorship W2013507617A5026919131 @default.
- W2013507617 hasAuthorship W2013507617A5051619233 @default.
- W2013507617 hasAuthorship W2013507617A5053975374 @default.
- W2013507617 hasAuthorship W2013507617A5059338254 @default.
- W2013507617 hasAuthorship W2013507617A5062862642 @default.
- W2013507617 hasAuthorship W2013507617A5075915892 @default.
- W2013507617 hasAuthorship W2013507617A5083184392 @default.
- W2013507617 hasAuthorship W2013507617A5089299130 @default.
- W2013507617 hasBestOaLocation W20135076172 @default.
- W2013507617 hasConcept C121608353 @default.
- W2013507617 hasConcept C126322002 @default.
- W2013507617 hasConcept C141071460 @default.
- W2013507617 hasConcept C156957248 @default.
- W2013507617 hasConcept C2777982462 @default.
- W2013507617 hasConcept C2778494859 @default.
- W2013507617 hasConcept C2778764654 @default.
- W2013507617 hasConcept C2778975757 @default.
- W2013507617 hasConcept C2779159551 @default.
- W2013507617 hasConcept C2780210213 @default.
- W2013507617 hasConcept C2908647359 @default.
- W2013507617 hasConcept C31174226 @default.
- W2013507617 hasConcept C71924100 @default.
- W2013507617 hasConcept C99454951 @default.
- W2013507617 hasConceptScore W2013507617C121608353 @default.
- W2013507617 hasConceptScore W2013507617C126322002 @default.
- W2013507617 hasConceptScore W2013507617C141071460 @default.
- W2013507617 hasConceptScore W2013507617C156957248 @default.
- W2013507617 hasConceptScore W2013507617C2777982462 @default.
- W2013507617 hasConceptScore W2013507617C2778494859 @default.
- W2013507617 hasConceptScore W2013507617C2778764654 @default.
- W2013507617 hasConceptScore W2013507617C2778975757 @default.
- W2013507617 hasConceptScore W2013507617C2779159551 @default.